Mention CD4/CD8 ratio imbalance as indicator of covid severity / progression, Leronlimab protects CD8 lymphocytes, stabilizing cytokine cascade and preventing inflammation without compromising the immune system. Zero SAE's in five years of studies and > 1000 patients.